APA (7th ed.) Citation

MM, M., DM, C., SABA, G., A, S., N, T., V, S., . . . MK, S. (2022). Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function. Cardiovascular research, 118(7), 1785. https://doi.org/10.1093/cvr/cvab205

Chicago Style (17th ed.) Citation

MM, Mia, et al. "Loss of Yap/Taz in Cardiac Fibroblasts Attenuates Adverse Remodelling and Improves Cardiac Function." Cardiovascular Research 118, no. 7 (2022): 1785. https://doi.org/10.1093/cvr/cvab205.

MLA (9th ed.) Citation

MM, Mia, et al. "Loss of Yap/Taz in Cardiac Fibroblasts Attenuates Adverse Remodelling and Improves Cardiac Function." Cardiovascular Research, vol. 118, no. 7, 2022, p. 1785, https://doi.org/10.1093/cvr/cvab205.